Genetic Engineering and Biotechnology News: Opening New Lines of Attack Against Cardiovascular Disease

Mar 03, 2022

This article from Ashleen Knutsen explores the advancements being made in cardiovascular drugs, featuring Tenaya CSO Tim Hoey, Ph.D., explaining the potential of our adeno-associated virus (AAV) approach as a method to deliver gene therapy.